This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Genentech, Inc., F. Hoffmann-La Roche Ag. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chelmsford, GB (2014)
- Harlow, GB (2013 - 2016)
Company Filing History:
Years Active: 2013-2016
Title: The Innovator Profile: Charles Ellwood
Introduction:
Meet Charles Ellwood, a prolific inventor based in Harlow, GB, with a remarkable portfolio of 4 patents to his name. His dedication to advancing cancer therapeutics through innovative compounds has garnered significant attention in the scientific community.
Latest Patents:
Charles Ellwood's latest patents include groundbreaking inventions such as 1,7-diazacarbazoles and methods of use. These compounds act as kinase inhibitors, specifically targeting checkpoint kinase 1 (chk1) to combat cancer and hyperproliferative disorders. Additionally, his pharmaceutical compositions have shown promise in diagnosing and treating various forms of cancer in mammalian cells.
Career Highlights:
With a career marked by innovation, Charles Ellwood has made significant contributions while working at esteemed companies such as Genentech, Inc. and F. Hoffmann-la Roche Ag. His expertise in developing novel compounds for cancer treatment has been instrumental in shaping the landscape of modern therapeutics.
Collaborations:
Throughout his journey, Charles Ellwood has collaborated with esteemed professionals in the field, including Simon Charles Goodacre and Karen Williams. Their collective efforts have propelled the development of cutting-edge solutions for cancer treatment, showcasing the power of collaboration in driving meaningful scientific advancements.
Conclusion:
In conclusion, Charles Ellwood stands as a trailblazing inventor whose passion for revolutionizing cancer therapeutics has led to groundbreaking advancements in the field. His dedication to innovation, coupled with his collaborative spirit, continues to inspire future generations of inventors in the pursuit of transformative medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile